BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24089549)

  • 1. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
    Perusina Lanfranca M; Mostafa HH; Davido DJ
    J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
    Zheng Y; Gu H
    J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
    Negorev DG; Vladimirova OV; Maul GG
    J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1.
    Zheng Y; Samrat SK; Gu H
    J Virol; 2016 Dec; 90(23):10875-10885. PubMed ID: 27681131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
    Jan Fada B; Kaadi E; Samrat SK; Zheng Y; Gu H
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
    Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
    J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.
    Cuchet-Lourenço D; Anderson G; Sloan E; Orr A; Everett RD
    J Virol; 2013 Dec; 87(24):13422-32. PubMed ID: 24089555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.
    Cuchet-Lourenço D; Vanni E; Glass M; Orr A; Everett RD
    J Virol; 2012 Oct; 86(20):11209-22. PubMed ID: 22875967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication.
    Mostafa HH; Thompson TW; Davido DJ
    J Virol; 2013 Feb; 87(4):2109-19. PubMed ID: 23221554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
    Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.
    Everett RD; Boutell C; Pheasant K; Cuchet-Lourenço D; Orr A
    J Virol; 2014 Mar; 88(5):2763-74. PubMed ID: 24352468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.
    Cuchet D; Sykes A; Nicolas A; Orr A; Murray J; Sirma H; Heeren J; Bartelt A; Everett RD
    J Cell Sci; 2011 Jan; 124(Pt 2):280-91. PubMed ID: 21172801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
    Lu Y; Orr A; Everett RD
    J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.
    Everett RD; Parada C; Gripon P; Sirma H; Orr A
    J Virol; 2008 Mar; 82(6):2661-72. PubMed ID: 18160441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Recognition by the E3 Ubiquitin Ligase of HSV-1 ICP0 Enhances the Degradation of PML Isoform I to Prevent ND10 Reformation in Late Infection.
    Jan Fada B; Guha U; Zheng Y; Reward E; Kaadi E; Dourra A; Gu H
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.
    Gu H; Roizman B
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8963-8. PubMed ID: 12855769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes.
    Cuchet-Lourenço D; Boutell C; Lukashchuk V; Grant K; Sykes A; Murray J; Orr A; Everett RD
    PLoS Pathog; 2011 Jul; 7(7):e1002123. PubMed ID: 21779164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression.
    Negorev DG; Vladimirova OV; Ivanov A; Rauscher F; Maul GG
    J Virol; 2006 Aug; 80(16):8019-29. PubMed ID: 16873258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins.
    Everett RD; Boutell C; McNair C; Grant L; Orr A
    J Virol; 2010 Apr; 84(7):3476-87. PubMed ID: 20106921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.